Sensydia
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10880 Wilshire Blvd Ste 1101 Ofc 1148, L...Website
www.sensydia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Sensydia
Sensydia specializes in advancing cardiovascular and critical patient care through its innovative Cardiac Performance System (CPS), which allows for rapid, non-invasive assessment of key hemodynamic metrics. The CPS platform is designed for use in hospitals and cardiology offices, enabling healthcare professionals to make informed decisions regarding patient care without the need for specialized equipment. By simplifying the acquisition of advanced hemodynamic measures, Sensydia aims to improve outcomes for heart failure and other critical cardiovascular conditions while reducing costs and readmissions. The company is committed to making vital hemodynamic measurements widely accessible to enhance patient care.Explore more
Sensydia Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sensydia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Sensydia launches new products
Earning: See what the market has to say on Sensydia recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sensydia, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sensydia had a recent Job posting/layoffs
Check out if Sensydia is spiking on competitors!
Funding: Get notified immidiatlly once Sensydia has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sensydia
Check if Sensydia has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Sensydia
Find 3 more new buyers
Compare Similar Companies to Sensydia
Compare insights from companies similar to Sensydia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sensydia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sensydia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sensydia.
Sensydia financials insights
Gather financial insights about Sensydia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$8M
Grant
$3M
Sensydia Tech Stack
A closer look at the technologies used by Sensydia
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Commentary
Person-Based
Executive Moves, Product Marketing, Advertising, Personnel Moves, Business Development, Corporate Strategy, Healthcare Technology, Marketing Operations, Operations
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Person-Based
Sensydia News & Media
Sensydia Completes Fifth Study for Heart-Sound AI
LOS ANGELES--(BUSINESS WIRE)--Non-invasive cardiac assessment company Sensydia announced today that it has completed its 50-subject development study at the University of Minnesota (UMN). This study was conducted at UMN to collect data for its innovative AI-powered, non-invasive Cardiac Performance System (CPS™) that uses heart sound analysis to enable earlier detection and more effective therapy guidance for patients suffering from heart failure and pulmonary hypertension. Sensydia is developiSensydia: Non-Invasive Cardiac Diagnostic Company Secures $3 Million NIH Grant
Sensydia - a non-invasive cardiac diagnostic company - announced recently that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).Cardiac-Focused Company Receives NIH Grant - Los Angeles Business Journal
Westwood-based Sensydia Corp. has received a $3 million grant from the National Institutes of Health. Learn what it will be used for.Biotech startup Sensydia secures $3M in NIH funding grant to revolutionize heart disease screening
Heart disease is the leading cause of death among people of all racial and ethnic groups in the United States. According to the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds in the United States […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sensydia
Sign Up For FreeTo access detailed company insights
Sensydia specializes in advancing cardiovascular and critical patient care through its innovative Cardiac Performance System (CPS), which allows for rapid, non-invasive assessment of key hemodynamic metrics. The CPS platform is designed for use in hospitals and cardiology offices, enabling healthcare professionals to make informed decisions regardi... Read More
